If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
21st Jun 20185:02 pmRNSHolding in Company
20th Jun 20181:07 pmRNSHolding in Company
19th Jun 20184:58 pmRNSHolding in Company
18th Jun 20184:33 pmRNSNotification of Major Holdings
13th Jun 20183:52 pmRNSHolding in Company
1st Jun 20181:16 pmRNSFinal Dividend for 2017
31st May 201810:09 amRNSNotification of Major Holdings
30th May 20184:57 pmRNSTR1 Notification
24th May 20182:31 pmRNSResults of Annual General Meeting
24th May 20187:00 amRNSTrading Update
23rd Apr 20185:03 pmRNSNotice of AGM
19th Apr 20184:49 pmRNSDirector/PDMR Shareholding
19th Apr 20189:50 amRNSHolding(s) in Company
16th Apr 20183:01 pmRNSDirector/PDMR Shareholding
4th Apr 20181:35 pmRNSHoldings in Company
4th Apr 20181:30 pmRNSHoldings in Company
14th Mar 20183:08 pmRNSHoldings in Company
8th Mar 20184:43 pmRNSDirector/PDMR Shareholding
6th Mar 20185:00 pmRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNSDirectorate Change
6th Mar 20187:00 amRNSPreliminary Results for year end 31 December 2017
5th Mar 201812:07 pmRNSSecond Price Monitoring Extn
5th Mar 201812:02 pmRNSPrice Monitoring Extension
22nd Feb 20187:00 amRNSAcquisition of AboveNation Media, LLC
19th Feb 201812:08 pmRNSSecond Price Monitoring Extn
19th Feb 201812:02 pmRNSPrice Monitoring Extension
16th Feb 20184:40 pmRNSSecond Price Monitoring Extn
16th Feb 20184:35 pmRNSPrice Monitoring Extension
15th Feb 201812:02 pmRNSPrice Monitoring Extension
11th Jan 20184:35 pmRNSPrice Monitoring Extension
19th Dec 20179:27 amRNSBoard Changes
18th Dec 201712:07 pmRNSSecond Price Monitoring Extn
18th Dec 201712:02 pmRNSPrice Monitoring Extension
14th Dec 20177:00 amRNSTrading Update
13th Dec 201712:07 pmRNSSecond Price Monitoring Extn
13th Dec 201712:02 pmRNSPrice Monitoring Extension
12th Dec 201712:21 pmRNSNotice of Results
4th Dec 201711:01 amRNSNotification of Total Voting Rights and Capital
6th Nov 20172:41 pmRNSDirector/PDMR Shareholding
3rd Nov 20177:00 amRNSAdditional Listing
9th Oct 20172:31 pmRNSHolding(s) in Company
5th Oct 20173:45 pmRNSScrip Dividend Alternative
4th Oct 20177:00 amRNSCapital Markets Day
2nd Oct 20174:00 pmRNSDirectorate Change
28th Sep 20174:00 pmRNSDirector/PDMR Shareholding
21st Sep 20179:41 amRNSHolding(s) in Company
15th Sep 20172:00 pmRNSHolding(s) in Company
12th Sep 201710:41 amRNSHolding(s) in Company
6th Sep 20179:00 amRNSAppointment of Joint Broker
1st Aug 201710:34 amRNSVoting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.